Healthcare
•3753 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3753)
| Company | Market Cap | Price |
|---|---|---|
|
VYST
Vystar Corporation
RxAir medical-grade air purification devices and FDA-cleared units position the company in medical devices and biometrics.
|
$1.26M |
$0.06
|
|
AURX
Nuo Therapeutics, Inc.
Aurix System is a wound care device used for chronic wounds (direct product).
|
$972618 |
$1.90
|
|
SGBX
Safe & Green Holdings Corp.
Medical segment includes point-of-care solutions and the Sanitec disinfecting system, aligning with Medical Devices & Biometrics.
|
$845455 |
$1.74
-6.72%
|
|
WLDS
Wearable Devices Ltd.
Biometric authentication and biometric sensing features embedded in the Mudra platform align with Medical Devices & Biometrics.
|
$806508 |
$1.14
-2.56%
|
|
AEMD
Aethlon Medical, Inc.
Hemopurifier is a blood purification device, the core product offering of Aethlon Medical.
|
$758823 |
$3.08
+13.82%
|
|
NLSP
NLS Pharmaceutics AG
Kadimastem's allogeneic cell-therapy platform (IsletRx, AstroRx) and NLSP's merger create a clear Cell Therapy business line.
|
$745651 |
$0.79
-67.48%
|
|
INIS
International Isotopes Inc.
Core product: INIS manufactures radiopharmaceutical drugs (I-131) used for diagnostic imaging and therapy.
|
$677144 |
$0.07
|
|
PRPH
ProPhase Labs, Inc.
BE-Smart diagnostic test and RUO/LDT commercialization imply laboratory testing and advisory services.
|
$669852 |
$0.36
+111.74%
|
|
CDT
CDT Equity Inc.
AZD1656/AZD5658 are small-molecule therapeutics licensed for development.
|
$543509 |
$1.41
+4.44%
|
|
SLRX
Salarius Pharmaceuticals, Inc.
Salarius operates as a clinical-stage biotech focused on oncology therapies (e.g., LSD1 inhibitor seclidemstat) and develops cancer treatments.
|
$397571 |
$0.74
-5.36%
|
|
ZVSA
ZyVersa Therapeutics, Inc.
IC 100 is a humanized monoclonal IgG4 antibody targeting ASC, classifiable as Monoclonal Antibody Therapeutics.
|
$359547 |
$0.14
|
|
CMND
Clearmind Medicine Inc.
CMND-100 is an oral small-molecule therapeutic candidate, categorizing the company under Oral Small Molecule Therapeutics.
|
$320925 |
$2.49
-5.32%
|
|
TIRX
Tian Ruixiang Holdings Ltd
Core product is health insurance solutions enabled by AI-driven tech via Ucare platform.
|
$234048 |
$0.50
+7.81%
|
|
RGBP
Regen BioPharma, Inc.
RGBP focuses on oncology/s Cancer immunotherapy and regenerative medicine, aligning with Biotech - Oncology.
|
$224038 |
$0.01
|
|
FCHS
First Choice Healthcare Solutions, Inc.
The company is pivoting to operate outpatient primary care clinics / ambulatory services led by nurse practitioners.
|
$197750 |
$0.01
|
|
MSPR
MSP Recovery, Inc.
Biometric technology used for patient verification and data integrity.
|
$94263 |
$0.20
+192.30%
|
|
PLRZ
Polyrizon Ltd.
Polyrizon's core offering is a proprietary intranasal hydrogel-based drug delivery platform (Capture & Contain and Trap & Target) used to deliver allergy blockers and CNS-targeted APIs.
|
$43478 |
$15.54
|
|
CERO
CERo Therapeutics Holdings, Inc.
CER-T is a cell therapy platform with lead candidate CER-1236, indicating direct cell-based therapeutic products.
|
$15483 |
$0.10
+141.50%
|
|
EMMA
Emmaus Life Sciences, Inc.
Endari is an oral small-molecule therapeutic (L-glutamine) marketed by Emmaus Life Sciences for sickle cell disease.
|
$14040 |
$0.01
|
|
WOK
WORK Medical Technology Group Ltd.
Company directly manufactures disposable medical device consumables sold globally (e.g., masks, breathing circuits, endotracheal tube holders).
|
$3502 |
$2.38
+0.85%
|
|
SMFL
Smart for Life, Inc.
SMFL owns manufacturing facilities (BSNM and DSO) and provides contract manufacturing for branded and contract-made nutraceutical products.
|
$558 |
$0.00
|
|
NCNA
NuCana plc
NuCana is a clinical-stage oncology biotech focusing on cancer therapeutics (NUC-3373 and NUC-7738).
|
N/A |
$3.30
-1.20%
|
Showing page 38 of 38 (3753 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
